News
NBRVF
0.0002
NaN%
--
Weekly Report: what happened at NBRVF last week (0203-0207)?
Weekly Report · 6d ago
Weekly Report: what happened at NBRVF last week (0127-0131)?
Weekly Report · 02/03 10:16
Weekly Report: what happened at NBRVF last week (0120-0124)?
Weekly Report · 01/27 10:17
Weekly Report: what happened at NBRVF last week (0113-0117)?
Weekly Report · 01/20 10:13
Weekly Report: what happened at NBRVF last week (0106-0110)?
Weekly Report · 01/13 10:14
Weekly Report: what happened at NBRVF last week (1230-0103)?
Weekly Report · 01/06 10:18
Weekly Report: what happened at NBRVF last week (1223-1227)?
Weekly Report · 12/30/2024 10:14
Weekly Report: what happened at NBRVF last week (1216-1220)?
Weekly Report · 12/23/2024 10:18
Weekly Report: what happened at NBRVF last week (1209-1213)?
Weekly Report · 12/16/2024 10:19
Weekly Report: what happened at NBRVF last week (1202-1206)?
Weekly Report · 12/09/2024 10:18
Weekly Report: what happened at NBRVF last week (1125-1129)?
Weekly Report · 12/02/2024 10:18
Weekly Report: what happened at NBRVF last week (1118-1122)?
Weekly Report · 11/25/2024 10:13
Weekly Report: what happened at NBRVF last week (1111-1115)?
Weekly Report · 11/18/2024 10:12
Weekly Report: what happened at NBRVF last week (1104-1108)?
Weekly Report · 11/11/2024 10:19
Weekly Report: what happened at NBRVF last week (1028-1101)?
Weekly Report · 11/04/2024 10:18
Weekly Report: what happened at NBRVF last week (1021-1025)?
Weekly Report · 10/28/2024 10:13
Weekly Report: what happened at NBRVF last week (1014-1018)?
Weekly Report · 10/21/2024 10:12
Weekly Report: what happened at NBRVF last week (1007-1011)?
Weekly Report · 10/14/2024 10:27
Weekly Report: what happened at NBRVF last week (0930-1004)?
Weekly Report · 10/07/2024 10:21
Weekly Report: what happened at NBRVF last week (0923-0927)?
Weekly Report · 09/30/2024 10:17
More
Webull provides a variety of real-time NBRVF stock news. You can receive the latest news about Nabriva Therapeutics Plc through multiple platforms. This information may help you make smarter investment decisions.
About NBRVF
Nabriva Therapeutics PLC is an Irland-based biopharmaceutical company engaged in the commercialization and development of anti-infective agents to treat serious infections. The Company's product, XENLETA (lefamulin injection, lefamulin tablets), is the first systemic pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP). XENLETA is designed to inhibit the synthesis of a specific protein on the bacterial ribosome, required for bacterial growth, by binding with high affinity and specificity at molecular targets different from those of other available antibiotic classes, causing cell death.